Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Spaepen

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Journal of Medical Economics|April 23, 2026
Enhancing economic modelling in obesity: integrating novel type 2 diabetes progression & obstructive sleep apnea remission - a UK case studyLieven Annemans, Erin Johansson, Erik Spaepen, et al.
The Journal of the Association of Physicians of India|February 10, 2025
Safety and Efficacy of Biosimilar Insulin Glargine (Basaglar) in Indian Patients with Type 2 Diabetes Mellitus: Results from a Multicenter, Open-Label, Single-Arm, Phase 4 Trial (ABEX)Banshi Saboo, Deepak Khandelwal, Piyush Desai, et al.
Canadian Journal of Diabetes|October 22, 2020
Conversations and Reactions Around Severe Hypoglycemia Study: Results of Hypoglycemia Experiences in Canadian Adults With Insulin-Treated Diabetes and Their CaregiversDonna Mojdami, Beth D Mitchell, Erik Spaepen, et al.
BMJ Open Ophthalmology|July 14, 2025
Polihexanide (PHMB) 0.08% versus currently used treatments for <i>Acanthamoeba</i> keratitis: indirect treatment comparisonsVincenzo Papa, Carlotta Galeone, Maria De Francesco, et al.
Annales D'Endocrinologie|December 6, 2021
Conversations and reactions around severe hypoglycemia (CRASH) global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers: Findings from the French cohortNicolas Chevalier, Alfred Penfornis, Jean-Pierre Riveline, et al.
Diabetes Research and Clinical Practice|March 2, 2019
Fasting experience of patients with Type 2 diabetes mellitus on insulin therapy during Ramadan: VISION Ramadan substudyAbdul Jabbar, Wan Mohd Izani Wan Mohamed, Erik Spaepen, et al.
Journal of Medical Economics|April 21, 2026
Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trialErin Johansson, John P H Wilding, Navneet Upadhyay, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 17, 2022
Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in SpainBeatrice Osumili, Esther Artime, Beth Mitchell, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|November 16, 2022
Conversations and Reactions Around Severe Hypoglycemia (CRASH) Study: Results From People With Diabetes and Caregivers in the United StatesFrank J Snoek, Erik Spaepen, Barbara A Nambu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 28, 2013
Should proximal LAD be treated differently? Insights from a large DES stent registryArthur Kerner, Eitan Abergel, Majdi Halabi, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Journal of Medical Economics|April 23, 2026
Enhancing economic modelling in obesity: integrating novel type 2 diabetes progression & obstructive sleep apnea remission - a UK case studyLieven Annemans, Erin Johansson, Erik Spaepen, et al.
The Journal of the Association of Physicians of India|February 10, 2025
Safety and Efficacy of Biosimilar Insulin Glargine (Basaglar) in Indian Patients with Type 2 Diabetes Mellitus: Results from a Multicenter, Open-Label, Single-Arm, Phase 4 Trial (ABEX)Banshi Saboo, Deepak Khandelwal, Piyush Desai, et al.
Canadian Journal of Diabetes|October 22, 2020
Conversations and Reactions Around Severe Hypoglycemia Study: Results of Hypoglycemia Experiences in Canadian Adults With Insulin-Treated Diabetes and Their CaregiversDonna Mojdami, Beth D Mitchell, Erik Spaepen, et al.
BMJ Open Ophthalmology|July 14, 2025
Polihexanide (PHMB) 0.08% versus currently used treatments for <i>Acanthamoeba</i> keratitis: indirect treatment comparisonsVincenzo Papa, Carlotta Galeone, Maria De Francesco, et al.
Annales D'Endocrinologie|December 6, 2021
Conversations and reactions around severe hypoglycemia (CRASH) global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers: Findings from the French cohortNicolas Chevalier, Alfred Penfornis, Jean-Pierre Riveline, et al.
Diabetes Research and Clinical Practice|March 2, 2019
Fasting experience of patients with Type 2 diabetes mellitus on insulin therapy during Ramadan: VISION Ramadan substudyAbdul Jabbar, Wan Mohd Izani Wan Mohamed, Erik Spaepen, et al.
Journal of Medical Economics|April 21, 2026
Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trialErin Johansson, John P H Wilding, Navneet Upadhyay, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 17, 2022
Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in SpainBeatrice Osumili, Esther Artime, Beth Mitchell, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|November 16, 2022
Conversations and Reactions Around Severe Hypoglycemia (CRASH) Study: Results From People With Diabetes and Caregivers in the United StatesFrank J Snoek, Erik Spaepen, Barbara A Nambu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 28, 2013
Should proximal LAD be treated differently? Insights from a large DES stent registryArthur Kerner, Eitan Abergel, Majdi Halabi, et al.
Pageof 5